S. Romain

Most-cited papers

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

   O. Abe, R. Abe, K. Enomoto, K. Kikuchi +331 more

   2005The Lancet7,428 citations

   Semantic Scholar

   Save

2. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

   M. Look, W. V. van Putten, M. Duffy, N. Harbeck +36 more

   2002Journal of the National Cancer Institute645 citations Open access

   Semantic Scholar

   Save

3. Influence of pregnancy on the outcome of breast cancer: A case‐control study

   P. Bonnier, S. Romain, J. Dilhuydy, F. Bonichon +5 more

   1997International Journal of Cancer249 citations Open access

   Semantic Scholar

   Save

4. Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features

   P. Bonnier, S. Romain, C. Charpin, Christian LeJeune +3 more

   1995International Journal of Cancer195 citations

   Semantic Scholar

   Save

5. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

   Frédéric Fina, S. Romain, L. Ouafik, J. Palmari +11 more

   2001British Journal of Cancer148 citations Open access

   Semantic Scholar

   Save

6. Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

   P. Bonnier, C. Charpin, Christian LeJeune, S. Romain +5 more

   1995International Journal of Cancer130 citations

   Semantic Scholar

   Save

7. Multiparametric prognostic evaluation of biological factors in primary breast cancer.

   F. Spyratos, P. Martin, K. Hacéne, S. Romain +6 more

   1992Journal of the National Cancer Institute129 citations

   Semantic Scholar

   Save

8. Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement Therapy

   P. Bonnier, S. Romain, P. Giacalone, F. Laffargue +2 more

   1995Obstetrics and Gynecology109 citations

   Semantic Scholar

   Save

9. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer

   C. Mazouni, F. Fina, S. Romain, L. Ouafik +3 more

   2010British Journal of Cancer98 citations Open access

   Semantic Scholar

   Save

10. Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival

    S. Desruisseau, J. Palmari, Corinne Giusti, S. Romain +2 more

    2006British Journal of Cancer88 citations Open access

    Semantic Scholar

    Save

11. Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

    P. Broët, S. Romain, A. Daver, G. Ricolleau +5 more

    2001Journal of Clinical Oncology87 citations

    Semantic Scholar

    Save

12. Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

    M. Look, W. V. van Putten, M. Duffy, N. Harbeck +36 more

    2003Thrombosis and Haemostasis85 citations

    Semantic Scholar

    Save

13. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.

    J. Foekens, S. Romain, M. Look, Pierre-Marie Martin +1 more

    2001Cancer Research74 citations

    Semantic Scholar

    Save

14. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.

    A. Chassevent, M. Jourdan, S. Romain, F. Descôtes +4 more

    2001Clinical Cancer Research68 citations

    Semantic Scholar

    Save

15. PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification.

    X. Muracciole, S. Romain, H. Dufour, J. Palmari +5 more

    2002International Journal of Radiation Oncology, Biology, Physics67 citations

    Semantic Scholar

    Save

16. Impact of menopausal hormone‐replacement therapy on clinical and laboratory characteristics of breast cancer

    P. Bonnier, F. Bessenay, Annie J. Sasco, Bassodeo Beedassy +5 more

    1998International Journal of Cancer66 citations Open access

    Semantic Scholar

    Save

17. c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse.

    M. Roux-Dosseto, S. Romain, N. Dussault, C. Desideri +4 more

    1992European Journal of Cancer55 citations

    Semantic Scholar

    Save

18. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.

    S. Romain, C. Laine Bidron, P. Martin, H. Magdelénat +5 more

    1995European Journal of Cancer51 citations

    Semantic Scholar

    Save

19. DNA‐synthesis enzyme activity: A biological tool useful for predicting anti‐metabolic drug sensitivity in breast cancer?

    S. Romain, P. Martin, J. Klijn, W. V. van Putten +3 more

    1997International Journal of Cancer46 citations Open access

    Semantic Scholar

    Save

20. Prognostic of DNA‐synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1–T2, N0–N1, M0 breast cancers: A retrospective multicenter study

    S. Romain, F. Spyratos, F. Descôtes, A. Daver +5 more

    2000International Journal of Cancer39 citations Open access

    Semantic Scholar

    Save

21. Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer

    S. Romain, I. Christensen, O. Chinot, I. Balslev +3 more

    1995International Journal of Cancer38 citations

    Semantic Scholar

    Save

22. Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study

    C. Jiguet-Jiglaire, S. Boissonneau, E. Denicolai, V. Hein +16 more

    2022Acta Neuropathologica Communications37 citations Open access

    Semantic Scholar

    Save

23. Transmission of apoptosis in human colorectal tumor cells exposed to capecitabine, Xeloda, is mediated via Fas.

    J. Ciccolini, F. Fina, K. Bezulier, S. Giacometti +6 more

    2002Molecular Cancer Therapeutics33 citations

    Semantic Scholar

    Save

24. [Cathepsin D: an independent prognostic factor in cancer of the breast].

    S. Romain, X. Muracciole, I. Varette, C. Bressac +2 more

    1990Bulletin du Cancer29 citations

    Semantic Scholar

    Save

25. Reliability and Discriminant Validity of HER2 Gene Quantification and Chromosome 17 Aneusomy Analysis by Real-Time PCR in Primary Breast Cancer

    P. Lamy, I. Nanni, F. Fina, F. Bibeau +6 more

    2006International Journal of Biological Markers28 citations Open access

    Semantic Scholar

    Save

26. Outcome of Epstein-Barr virus-associated primary breast cancer.

    C. Mazouni, F. Fina, S. Romain, L. Ouafik +2 more

    2015Molecular and clinical oncology27 citations Open access

    Semantic Scholar

    Save

27. Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool

    P. Tsvetkov, E. Tabouret, A. Roman, S. Romain +6 more

    2018OncoTarget25 citations Open access

    Semantic Scholar

    Save

28. Clinical relevance of amphiregulin and VEGF in primary breast cancers

    S. Desruisseau, Jaqueline Palmari, Corinne Giusti, S. Romain +2 more

    2004International Journal of Cancer25 citations Open access

    Semantic Scholar

    Save

29. DNA‐synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric s‐phase fraction and relative prognostic importance in node‐negative premenopausal patients

    S. Romain, P. Bendahl, O. Guirou, P. Malmström +2 more

    2001International Journal of Cancer24 citations Open access

    Semantic Scholar

    Save

30. Flow cytometric S-phase fraction measurement in breast carcinoma: Influence of software and histogram resolution.

    M. Jourdan, Magali Ferrero-Poüs, F. Spyratos, S. Romain +2 more

    2002Cytometry21 citations

    Semantic Scholar

    Save

31. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.

    S. Romain, J. Formento, O. Guirou, M. Francoual +2 more

    1994European Journal of Cancer21 citations

    Semantic Scholar

    Save

32. Biological heterogeneity of er‐positive breast cancers in the post‐menopausal population

    S. Romain, O. Chinot, O. Guirou, Marc Soullière +1 more

    1994International Journal of Cancer21 citations

    Semantic Scholar

    Save

33. Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

    S. Romain, O. Chinot, J. Klijn, W. V. Van Putten +4 more

    1994British Journal of Cancer19 citations Open access

    Semantic Scholar

    Save

34. [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].

    A. Chassevent, M. Jourdan, Magali Ferrero-Poüs, M. Colonna +4 more

    1999Bulletin du Cancer16 citations

    Semantic Scholar

    Save

35. Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report.

    S. Romain, F. Spyratos, O. Guirou, S. Deytieux +2 more

    1994European Journal of Cancer15 citations

    Semantic Scholar

    Save

36. Correlation of erbB-2 gene amplification with low levels of estrogen and/or progesterone receptors in primary breast cancer: do erbB-2 products delineate hormone-independent tumors?

    M. Roux-Dosseto, S. Romain, N. Dussault, Pierre-Marie Martin

    1989Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie15 citations

    Semantic Scholar

    Save

37. A nomogram predicting the probability of primary breast cancer survival at 2‐ and 5‐years using pathological and biological tumor parameters

    C. Mazouni, P. Bonnier, S. Romain, Pièrre-Marie Martin

    2011Journal of Surgical Oncology14 citations

    Semantic Scholar

    Save

38. Biochemical and immunohistochemical multiparametric analysis of steroid receptors and growth factor receptors in human normal endometrium in spontaneous cycles and after the induction of ovulation.

    J. Salat-Baroux, S. Romain, S. Alvarez, J. Antoine +4 more

    1994Human Reproduction14 citations

    Semantic Scholar

    Save

39. Is quantitative oestrogen receptor expression useful in the evaluation of the clinical prognosis? Analysis of a homogeneous series of 797 patients with prospective determination of the ER status using simultaneous EIA and IHC.

    C. Mazouni, P. Bonnier, A. Goubar, S. Romain +1 more

    2010European Journal of Cancer13 citations

    Semantic Scholar

    Save

40. [Prognostic value of thymidine kinase in cancer of the breast].

    S. Romain, J. L. Javre, S. Samperez, P. Jouan +4 more

    1990Bulletin du Cancer12 citations

    Semantic Scholar

    Save

41. Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer.

    S. Gilles, S. Romain, P. Casellas, L. Ouafik +8 more

    2003International Journal of Biological Markers10 citations

    Semantic Scholar

    Save

42. A nomogram to predict individual prognosis in node-negative breast carcinoma.

    C. Mazouni, F. Spyratos, S. Romain, F. Fina +3 more

    2012European Journal of Cancer9 citations Open access

    Semantic Scholar

    Save

43. Prognostic significance of tumor-related proteases as a function of the estrogen receptor status

    C. Mazouni, S. Romain, P. Bonnier, L. Ouafik +1 more

    2011Cancer Biology & Therapy9 citations Open access

    Semantic Scholar

    Save

44. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.

    Elias Krambovitis, G. Hatzidakis, Anastasia Hatzoglou, S. Romain +3 more

    1995Clinical Chemistry9 citations Open access

    Semantic Scholar

    Save

45. Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.

    S. Romain, F. Spyratos, C. Lainé-Bidron, C. Bouchet +4 more

    1995European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies9 citations

    Semantic Scholar

    Save

46. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours.

    S. Romain, C. Dussert, Pierre-Marie Martin

    1991European Journal of Cancer9 citations

    Semantic Scholar

    Save

47. Prognostic Significance of Autoantibodies to Laminin in the Sera of Breast Cancer Patients: A Preliminary Report

    M. R. Barbauche, S. Romain, S. Avrameas, L. Piana +1 more

    1994European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies7 citations Open access

    Semantic Scholar

    Save

48. EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols.

    P. Span, J. Heuvel, S. Romain, A. Piffanelli +3 more

    2000Anticancer Research6 citations

    Semantic Scholar

    Save

49. Résultats du traitement par chirurgie conservatrice et irradiation de 132 carcinomes canalaires in situ non palpables du sein

    R. Amalric, H. Brandone, A. Dubau, D. Hans +10 more

    19985 citations

    Semantic Scholar

    Save

50. Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer.

    P. Lamy, I. Nanni, F. Fina, F. Bibeau +6 more

    2006International Journal of Biological Markers4 citations

    Semantic Scholar

    Save